FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34808811000001104: Reslizumab 25mg/2.5ml solution for infusion vials 1 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105311001000001117 Reslizumab 25mg/2.5ml solution for infusion vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105311101000001116 Reslizumab 25mg/2.5ml solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial Has VMP Reslizumab 25mg/2.5ml solution for infusion vials true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial Has specific active ingredient Reslizumab true Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Is a True Reslizumab 25mg/2.5ml solution for infusion vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start